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 Internal mammary arteries (IMA) are routinely used for 
coronary artery bypass grafting (CABG), but can exhibit im-
pairment of endothelium-dependent vascular relaxation. The 
use of radial artery (RA) grafts for CABG has been recently 
reintroduced. The long-term patency of these grafts may de-
pend on the ability of these vessels to produce endothelium-
derived nitric oxide (NO). We therefore sought to determine 
if the RA exhibits better endothelial function compared with 
IMA harvested from the same patient. Using the organ bath 
technique, vessels were preconstricted with the thromboxane 
A2 analogue (U46619) and exposed to increasing concentra-
tions of either acetylcholine (ACh ), calcium ionophore A23187 
(A23187), or nitroglycerin (NTG). We prepared the rubbed 
RA for comparison of between RA with and without endo-
thelium on response to ACh relaxation. KCI and U46619
constricted　 RA　 (11.3±4.9g　 and　 16.0±4.3g　 respectively)
more　 than　 IMA(2.4±1.4g　 and　 4.5±1.7　 respectively).　 Both
RA and IMA relaxed 100% of the preconstricted tension to
NTG.　 ACh　 induced　 less　 relaxation　 in　 the　 IMA(28±24%)
when　 compared　 with　 the　 RA(49±16%)(p<0.05).　 A23187
demonstrated　 relaxation　 in　 both　 the　 RA(86±14%)and
IMA(76±18%),　 but　 there　 was　 no　 statistical　 difference.
RA without endothelium showed same response to ACh as 
IMAs. Compared with the IMA, the RA has better ACh induced 
endothelium-dependent relaxation. This pathway mainly in-
volves NO production which also inhibits the atherosclerotic 
process. Therefore, the RA may provide longer term graft 
patency than IMA.
Introduction 
 The internal mammary artery (IMA) is an important 
conduit for coronary artery surgery. Both short and long-
term patency are greater compared with the saphenous 
vein, and endothelium-dependent relaxation is greater 
in arterial grafts",". The ability to perform a complete 
arterial revascularization has been limited by the avail-
ability of vessels that can be harvested. Radial arteries 
(RA) and gastroepiploic arteries are considered to have 
increased vasospastic properties'-'). Although the RA was 
initially used for revascularization by Carpentier in 1971, 
this technique was previously abandoned because of a 
high incidence of vasospasm and low patency rates""). 
Recently, the use of RA grafts for coronary artery bypass 
grafting (CABG) has been reintroduced because it repre-
sents an additional option for an arterial graft'). Internal 
mammary arteries, although routinely used for coronary 
artery surgery, can exhibit impairment of endothelium-
dependent vascular relaxation, and their availability may 
be limited'). The long-term patency of arterial grafts 
may depend on the ability of these vessels to produce 
endothelium-derived nitric oxide (NO). Moreover, endo-
thelial injury predisposes to thrombosis, leukocyte ad-
hesion, and proliferation of smooth muscle cells in the 
arterial wall"'. We therefore sought to determine if the 
RA might exhibit better endothelial function as com-
pared to the IMA harvested from the same patient.
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Materials and Methods 
Vessel Preparation 
 Following institutional approval, residual human IMA 
and RA segments were collected from 18 patients fol-
lowing CABG. The discarded distal end was carefully 
removed and placed in 4 °C chilled modified Krebs-
Hepes buffer of the following composition (in g/L): 
NaC1, 6.9; KCI, 0.35; CaCl2, 0.373; MgSO4, 0.141; KH2PO4,
0.16; NaHCO3, 2.1; D-Glucose, 2.0; HEPES, 5.206; pH 7.40 
± 0.05. The both vessels were transferred to the labo-
ratory and then cleaned of adherent connective tissue 
and cut into 3mm ring segments immediately. The 
time delay between the vessels harvest and prepara-
tion was less than 30 minutes. 
Organ-Chamber Experiments 
  The rings were suspended between two wire hooks 
in organ chambers filled with 25 ml of Krebs-Henseleit 
solution (in g/L: NaCI, 6.9; KCI, 0.35; CaC12, 0.373; MgS 
04, 0.141; KH2PO4, 0.16; NaHCO3, 2.1; D-Glucose, 2.0; 371C,                                            °
pH 7.40 ± 0.05) aerated with 95%02 and 5 % C02!. The 
upper hook was connected to force transducer (Kent-
Scientific Corporation), and changes in isometric force 
were recorded (Mac Lab' system, Milford MA). After 
a resting tension (RA 2.0 g, IMA 2.5 g), defined by pre-
liminary studies, was progressively applied, the rings 
were allowed to stabilize for 30 minutes. The ring 
preparations were then precontracted with the KCI 
(60mM), washed 3 times with fresh buffer and allowed 
equilibrate for an additional 30 minutes. To prevent the 
effect of prostanoid, indomethacin was added first. After 
that, both arteries, which were constricted with the 
thromboxane A2 analogue, U46619 (0.1 nM) , were re-
laxed with increasing doses of acetylcholine (10-9to10-4 
M). The vessels were then randomly separated into two 
groups of calcium ionophore A23187 (A23187) (n=12) 
and nitroglycerin (NTG) (n=10). After additional wash-
ing and equilibration, indomethacin was added again and 
both groups were contracted with U46619. Cumulative 
dose-response curves were obtained by adding of 
A23187 (10-10-10-5-5M) or NTG (10-"-10-55 M) to the 
organ baths in 0.5 log-unit increments. 
Comparison of RA with and without endothelium 
 Seven RA with and without endothelium from the 
same patients were compared. Endothelium was removed 
by inserting microforceps inside the lumen of the ves-
sels and gently rubbing the surface. The vessels were 
constricted with KCl and U46619, and relaxed with 
ACh (n=7) according to the methods described above. 
Drugs and buffer solutions 
 The following drugs were used; U46619: 10 mg/ml in 
methyl acetate, a gift from Upjohn company, Kalamazoo, 
Michigan; KCl powder: Supplied by Malinckrodt, St. 
Louis, Missouri ; acetylcholine chloride : supplied by 
Sigma Chemical, St. Louis, Missouri; A23187 : supplied 
by Sigma Chemical, St. Louis, Missouri; nitroglycerin :
supplied by SoloPak Laboratories Inc., Elk Grove, Illinois; 
indomethacin : supplied by Sigma Chemical, St. Louis, 
Missouri 
 An aliquot of U46619 was evaporated to dryness 
under nitrogen, redissolved in absolute ethanol to 
1 mM and then diluted to 10-'M in distilled water. 
A23187 was diluted with ethanol to 1mM and dissolved 
in distilled water to 10-4-10-7 M. The concentration of 
ethanol in the bath did not exceed 0.1 %. 4M KCI solu-
tion was used as a stock solution. All other drugs were 
diluted in distilled water. Drugs were prepared 5 min-
utes before each experiment and stored on ice. The 
concentrations of the drugs are expressed as final 
moles/litter concentration in the bath. 
Data and Statistical analysis 
 Relaxation was expressed as a percentage of U46619 
induced contraction (=100%). Responses from vascular 
segments were averaged for one patient's RA and IMA. A 
Mann-Whitney U test was used to compare the data. 
P<0.05 was considered significant. In all experiments, 
n equaled the number of patients from whom the both 




 All patients (n= 18) were men 58.3 ± 8.1 years old. 
There were 5 patients with a history of smoking, 14 
with hypertension, 5 with non-insulin-dependent diabe-
tes mellitus, and 11 with hypercholesterolemia. 
Vessel constriction and relaxation 
 There were significant differences in constriction and 
relaxation responses between RA and IMA. Addition of 
KCI resulted in constriction of 11.3 ± 4.9g in RA and 
2.4 ± 1.4g in IMA. For U46619 constriction was 16.0 
± 4.3g and 4.5 ± 1.7g respectively. Acetylcholine re-
laxed RA much better than IMA, Emax 49 ± 16 % (range 
from 26 to 74%) and Emax 28 ± 24 % (range from 1 to 
79%) respectively (Figures l and 2). The degree of ACh 
relaxation of RA without endothelium and IMA with 
endothelium were very similar and there was no sig-
nificant difference between the two vessels. Also, there 
was no significant difference in the response to A23187 
in both arteries. Relaxation were 86 ± 14% (range from 
54 to 100%) and 76 ± 18% (range from 45 to 100%) in 
RA and IMA respectively (Figure 3). Similarly, there
was no difference in NTG effects on both vessels. 
Highest concentration of NTG caused 100% relaxation 
in both RA and IMA (Figure 4 and Table 1).
Figure 3. Concentration-response curve of calcium ionophore, 
A23187, on human internal mammary artery (IMA; ®) and 
radial artery (RA; 0). Both arteries were preconstricted with 
U46619. Data are shown as mean ± S D (n = 12)
Figure 1. Concentration-response curve of acetylcholine (ACh ) 
on human internal mammary artery (IMA; ®) and radial ar-
tery (RA; 0). Both arteries were preconstricted with U46619. 
Data are shown as mean ± SD (n = 12,*p<0.05 versus IMA). 
RA rubbed endothelium is shown as A (n=7)
Figure 2. The response of radial artery (RA) and internal 
mammary artery (IMA) rings to acetylcholine 10-6 M.
Figure 4. Concentration-response curve of nitroglycerin 
(NTG) on human internal mammary artery (IMA; ®) and 
radial artery (RA; 0). Both arteries were preconstricted with 
U46619. Data are shown as mean ± SD (n = 10).
Table 1. The EC5o and Ema, of acetylcholine, A23187 and nitroglycerin on radial artery and internal mammary artery
                        EC50 (mol/L) Em. (%) 
                radial artery internal mammary radial artery internal mammary 
                              artery artery
acetylcholine 1.47 ± 1.4 x 10-7 1.73 ± 1.6 x 10"7 NS 49.0 ± 16.0 27.9 ± 23.6 
A23487 2.26 ± 2.3 x 10"' 1.57 ± 1.4 x 10-' NS 86.2 ± 14.0 76.2 ± 18.3 NS 
nitroglycerin 9.17 ± 5.5 x 10.9 2.4 ± 2.6 x 10-9 NS >100 >100 NS
Data are shown as mean ± SD 
*P<0 .05 radial artery versus internal mammary artery
Discussion 
 We noted that the RA demonstrated better endothe-
lial function than IMA as measured by relaxation re-
sponse to ACh. These findings may affect long-term 
patency of vascular grafts. Our study is also the first 
to directly compare IMA and RA from the same pa-
tient, and evaluate endothelial function in both grafts. 
This is important in the potential decision for isolated 
or combined vascular grafting during coronary artery 
surgery. Although thromboxane A2 constricts the RA 
more than IMA, this difference can be explained by 
the greater amount of vascular smooth muscle in the 
RA". On the other hand, RA and IMA showed same 
relaxation to A23187 and NTG. Therefore, our study 
suggests RA have better receptor-mediated endothelial 
function than IMA. 
 Different arteries including the internal mammary ar-
tery, gastroepiploic artery"', inferior epigastric artery"', 
splenic artery 13,14'' have been used as a conduit for CABG. 
The RA was first used for coronary revascularization 
in 1971, but this practice was abandoned due to narrow-
ing and occlusion several years later. Although it has 
not been established whether the RA has long-term 
patency, Acar reported that RA grafting showed excel-
lent short term patency rates. Early angiographic con-
trols (less than 2 weeks) were obtained in the first 50 
consecutive patients. They studied and revealed 56 of 
56 patent RA grafts, 48 of 48 patent left IMA grafts, 11 
of 11 patent right IMA grafts, 14 of 18 patent free IMA 
grafts, and 8 of 9 patent vein grafts. For these reasons, 
RA grafting was reintroduced as a conduit for CABG2'. 
 The advantage of using a RA conduit is involved that 
it represents an arterial graft accustomed to systemic 
pressures, and its diameter corresponds exactly to the 
diameter of most coronary arteries, and the quality of 
its wall offers good technical conduits for coronary 
and aortic anastomosis, and its length allows it to reach 
all target vessels on the surface of the heart. Moreover, 
in the some instances, two distinct grafting sites can 
be performed using two segments of the same radial 
artery'). Further, the RA is usually macroscopically 
normal and rarely affected by atherosclerosis2.15). After 
the initial reports by Acar, additional investigators have 
suggested the usefulness of RA as a conduit for CABG, 
because of high patency rates16 18). 
 The characteristics that influence long-term patency 
are multiple. RA is a muscular artery and was considered 
to be prone to vasospasm, an important cause of low 
patency6). He-Wei described many spasmogens for blood 
vessels that may include endothelium derived contract-
ing factor (endothelin-1), prostanoids (thromboxane A2, 
prostaglandin F2a ),circulating sympathomimetic factor
(a -adrenoceptor agonist (norepinephrine, methoxamine, 
phenylephrine) ), platelet derived contracting substances 
(5-hydroxytryptamine, thromboxane A2 ),substances 
released from mast cells and basophils (histamine), 
muscarinic receptor agents, factors arising from renin 
angiotensin system (angiotensin II) and KCl 19'. As shown 
not only in this study but other studies also, RA con-
stricts considerably more than IMA when exposed to dif-
ferent constrictor agents, which may be the results of 
greater smooth muscle content',","). Endothelium, al-
though it releases vasoconstricting factors too, also 
protects the smooth muscle from vasoconstrictor effects 
of such agents as thromboxane A2 , norepinephrine, 
endothelin-1, angiotensin II, for example during peri-
operation period when plasma concentrations of these 
constrictors are increased"-"'. Moreover endothelium-
dependent vascular relaxation may contribute to the 
long-term patency of arterial grafts as NO inhibits 
atherosclerosis. The present study suggests that RA 
have better endothelium function than IMA, because 
of better relaxation to ACh but not to A23187. ACh 
produces NO by stimulating muscarinic receptors on 
endothelial membranes signaling, but in patients with 
atherosclerotic disease, the G-protein is impaired25 27 . 
However, our data suggests that the endothelium re-
ceptor mediated function of RA is better than IMA in 
patients with vascular disease, a finding that may re-
late to long-term patency. 
 Several studies report the IMA exhibits impairment of 
endothelium-dependent vascular relaxation"). Our study 
is the first to directly compare the IMA with the RA in 
the same patient, and evaluate endothelial function. In 
patients who have coronary artery disease, atherosclerotic 
change is likely to exist in IMA as well. RA grafting 
may represent an alternative conduit to IMA. Further 
clinical studies are needed to support this hypothesis.
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